Timothy C Dec
Senior Vice-President & CFO. Files against SUPN. Everything below is filed with the SEC within two business days of the trade. Filed as DEC TIMOTHY C.
Every reported line
Purchases, sales, grants, option exercises and shares withheld for tax.
| Company | Action | Value |
|---|---|---|
| SUPNSupernus Pharmaceuticals Inc2026-08-12 | Option exercise | — |
| SUPNSupernus Pharmaceuticals Inc2026-08-12 | Withheld for tax | $28.1K |
| SUPNSupernus Pharmaceuticals Inc2026-08-12 | Option exercisederivative | — |
| SUPNSupernus Pharmaceuticals Inc2026-07-29 | Grantderivative | — |
Source: SEC Form 4 and Form 144 filings, via EDGAR. Form 144 carries no filer identifier, so those notices are matched to this page by name alone. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
Follow Timothy C Dec by email
Timothy C Dec's new Form 4 trades, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.